Allison Nixon

Allison is a Principal Scientist 1, Antibody Discovery at AlivaMab Discovery Services (ADS). Allison has over 13 years of laboratory experience in academic and biotech settings spanning multiple research disciplines. Allison has extensive experience in cancer stroma biology with a focus on therapeutic antibody discovery. She has over four years of industry experience leading biotherapeutic drug discovery programs from target identification/validation through discovery campaigns and from lead selection/optimization to in vivo studies. Prior to joining ADS, Allison was Lead Biologist at Phenomic AI, a Toronto- and Cambridge, MA-based biotech startup. Allison received her Ph.D. in molecular genetics from the University of Toronto.